• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过氢原子转移参与设计的用于增强光动力疗法的光动力剂。

The Photodynamic Agent Designed by Involvement of Hydrogen Atom Transfer for Enhancing Photodynamic Therapy.

作者信息

Fan Zhuo, Teng Kun-Xu, Xu Yuan-Yuan, Niu Li-Ya, Yang Qing-Zheng

机构信息

Institution Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, P. R. China.

出版信息

Angew Chem Int Ed Engl. 2025 Jan 2;64(1):e202413595. doi: 10.1002/anie.202413595. Epub 2024 Nov 14.

DOI:10.1002/anie.202413595
PMID:39448378
Abstract

Although Type-I photodynamic therapy has attracted increasingly growing interest due to its reduced dependence on oxygen, the design of effective Type-I photosensitizers remains a challenge. In this work, we report a design strategy for Type-I photosensitizers by the involvement of hydrogen atom transfer (HAT). As a proof of concept, a HAT-involved Type-I PS, which simultaneously generates superoxide and carbon-centered radicals under light-irradiation, was synthesized. This photosensitizer is comprised of a fluorene-substituted BODIPY unit as an electron acceptor covalently linked with a triphenylamine moiety as an electron donor. Under light-irradiation, photo-induced intramolecular electron transfer occurs to generate the BODIPY anion radical and triphenylamine cation radical. The former transfers electrons to oxygen to generate O ⋅, while the latter loses a proton to produce a benzyl carbon-centered radical which is well characterized. The resulting carbon-centered radicals efficiently oxidize NADH by HAT reaction. This photosensitizer demonstrates remarkable photocytotoxicity even under hypoxic conditions, along with outstanding in vivo antitumor efficacy in mouse models bearing HeLa tumors. This work offers a novel strategy for the design of Type-I photosensitizers by involvement of HAT.

摘要

尽管I型光动力疗法因其对氧气的依赖性降低而越来越受到关注,但设计有效的I型光敏剂仍然是一项挑战。在这项工作中,我们报告了一种通过氢原子转移(HAT)来设计I型光敏剂的策略。作为概念验证,合成了一种涉及HAT的I型光敏剂,其在光照下同时产生超氧阴离子和碳中心自由基。这种光敏剂由芴取代的BODIPY单元作为电子受体与作为电子供体的三苯胺部分共价连接而成。在光照下,发生光诱导的分子内电子转移,生成BODIPY阴离子自由基和三苯胺阳离子自由基。前者将电子转移给氧气生成O₂•,而后者失去一个质子产生一个特征明确的苄基碳中心自由基。产生的碳中心自由基通过HAT反应有效地氧化NADH。这种光敏剂即使在缺氧条件下也表现出显著的光细胞毒性,在携带HeLa肿瘤的小鼠模型中具有出色的体内抗肿瘤疗效。这项工作通过涉及HAT为I型光敏剂的设计提供了一种新策略。

相似文献

1
The Photodynamic Agent Designed by Involvement of Hydrogen Atom Transfer for Enhancing Photodynamic Therapy.通过氢原子转移参与设计的用于增强光动力疗法的光动力剂。
Angew Chem Int Ed Engl. 2025 Jan 2;64(1):e202413595. doi: 10.1002/anie.202413595. Epub 2024 Nov 14.
2
Moderately Heavy Atom-Substituted BODIPY Photosensitizer with Mitochondrial Targeting Ability for Imaging-Guided Photodynamic Therapy.具有线粒体靶向能力的中等重原子取代的BODIPY光敏剂用于成像引导的光动力治疗
ACS Appl Bio Mater. 2024 Dec 16;7(12):8294-8304. doi: 10.1021/acsabm.4c01108. Epub 2024 Nov 27.
3
Photo-Induced Disproportionation-Mediated Photodynamic Therapy: Simultaneous Oxidation of Tetrahydrobiopterin and Generation of Superoxide Radicals.光致歧化介导的光动力疗法:四氢生物蝶呤的同时氧化和超氧自由基的生成。
Angew Chem Int Ed Engl. 2024 Mar 18;63(12):e202318783. doi: 10.1002/anie.202318783. Epub 2024 Feb 13.
4
A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy.一种具有荧光共振能量转移特性的谷胱甘肽响应型光敏剂,用于成像引导靶向光动力治疗。
Eur J Med Chem. 2020 May 1;193:112203. doi: 10.1016/j.ejmech.2020.112203. Epub 2020 Mar 6.
5
A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy.一种简单的过氧化氢激活型 Bodipy,用于肿瘤成像和 I/II 型光动力治疗。
J Mater Chem B. 2024 Nov 6;12(43):11165-11171. doi: 10.1039/d4tb01650e.
6
Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.线粒体靶向硒吩修饰基于 BODIPY 的光敏剂用于治疗缺氧癌细胞。
ChemMedChem. 2019 Nov 20;14(22):1879-1886. doi: 10.1002/cmdc.201900380. Epub 2019 Nov 5.
7
Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical.用于同时氧化 NADH 和生成超氧自由基的超分子光动力剂。
Nat Commun. 2022 Oct 19;13(1):6179. doi: 10.1038/s41467-022-33924-3.
8
Constructing Heavy-Atom-Free Photosensitizers for Hypoxic Tumor Phototherapy Based on Donor-Excited Photoinduced Electron-Transfer-Driven Type-I and Type-II Mechanisms.基于给体激子型光诱导电子转移驱动的 I 型和 II 型机制构建乏重原子光动力治疗剂用于缺氧肿瘤治疗。
ACS Appl Mater Interfaces. 2024 Aug 7;16(31):40428-40443. doi: 10.1021/acsami.4c02175. Epub 2024 Jul 23.
9
BODIPY-Ruthenium(II) Bis-Terpyridine Complexes for Cellular Imaging and Type-I/-II Photodynamic Therapy.BODIPY-钌(II)双三联吡啶配合物用于细胞成像和 I/II 型光动力治疗。
Inorg Chem. 2021 Nov 1;60(21):16178-16193. doi: 10.1021/acs.inorgchem.1c01850. Epub 2021 Oct 21.
10
Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.缺氧条件下BODIPY衍生的I型光敏剂在光动力治疗后的自动失活
Chembiochem. 2025 Feb 1;26(3):e202400767. doi: 10.1002/cbic.202400767. Epub 2024 Nov 28.

引用本文的文献

1
Umbrella review of photodynamic therapy for cancer: efficacy, safety, and clinical applications.癌症光动力疗法的伞状综述:疗效、安全性及临床应用
Front Oncol. 2025 Aug 4;15:1528314. doi: 10.3389/fonc.2025.1528314. eCollection 2025.
2
Photo-uncaging of a ferrocene-bridged dinuclear iridium(iii) complex for three-photon photoimmunotherapy against hypoxic melanoma.用于抗缺氧黑色素瘤的三光子光免疫疗法的二茂铁桥连双核铱(III)配合物的光解笼效应
Chem Sci. 2025 Jul 10. doi: 10.1039/d5sc04006j.
3
Breaking the heavy-atom paradigm: weak-donor-engineered triplet harvesting in BODIPY photosensitizers for immunogenic pyroptosis therapy.
打破重原子范式:用于免疫原性细胞焦亡治疗的BODIPY光敏剂中弱供体工程化三线态捕获
Chem Sci. 2025 Jul 14. doi: 10.1039/d5sc03466c.
4
A nuclear targeted type-I photosensitizer for anti-tumor therapy.一种用于抗肿瘤治疗的核靶向I型光敏剂。
Chem Sci. 2025 Jun 20. doi: 10.1039/d5sc02476e.
5
"Dual lock-and-key" triggered and endoplasmic reticulum targeting nanophotosensitizers for activatable Type-I photodynamic and photothermal therapies.用于可激活的I型光动力和光热疗法的“双锁钥”触发及内质网靶向纳米光敏剂
Chem Sci. 2025 Jun 9. doi: 10.1039/d5sc01987g.
6
Conjugated Polymer-Photosensitizers for Cancer Photodynamic Therapy and Their Multimodal Treatment Strategies.用于癌症光动力疗法的共轭聚合物光敏剂及其多模态治疗策略
Polymers (Basel). 2025 May 5;17(9):1258. doi: 10.3390/polym17091258.